Japan
· Delayed Price · Currency is JPY Sundrug Co.,Ltd. Statistics
Total Valuation
Sundrug Co.,Ltd. has a market cap or net worth of JPY 472.25 billion. The enterprise value is 444.90 billion.
| Market Cap | 472.25B |
| Enterprise Value | 444.90B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | Sep 27, 2024 |
Share Statistics
Sundrug Co.,Ltd. has 116.95 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Shares Outstanding | 116.95M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 4.60% |
| Owned by Institutions (%) | 23.46% |
| Float | 67.01M |
Valuation Ratios
The trailing PE ratio is 16.00 and the forward PE ratio is 15.29. Sundrug Co.,Ltd.'s PEG ratio is 3.84.
| PE Ratio | 16.00 |
| Forward PE | 15.29 |
| PS Ratio | 0.62 |
| PB Ratio | 1.86 |
| P/FCF Ratio | n/a |
| PEG Ratio | 3.84 |
Enterprise Valuation
| EV / Earnings | 15.07 |
| EV / Sales | 0.58 |
| EV / EBITDA | 7.75 |
| EV / EBIT | 10.71 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.70 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.60 |
| Debt / FCF | n/a |
| Interest Coverage | 933.71 |
Financial Efficiency
Return on equity (ROE) is 12.02% and return on invested capital (ROIC) is 9.98%.
| Return on Equity (ROE) | 12.02% |
| Return on Assets (ROA) | 6.82% |
| Return on Capital (ROIC) | 9.98% |
| Revenue Per Employee | 114.71M |
| Profits Per Employee | 4.43M |
| Employee Count | 6,662 |
| Asset Turnover | 1.99 |
| Inventory Turnover | 6.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.29% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -3.29% |
| 50-Day Moving Average | 4,127.70 |
| 200-Day Moving Average | 4,293.09 |
| Relative Strength Index (RSI) | 40.34 |
| Average Volume (20 Days) | 271,785 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sundrug Co.,Ltd. had revenue of JPY 764.20 billion and earned 29.52 billion in profits. Earnings per share was 252.38.
| Revenue | 764.20B |
| Gross Profit | 193.26B |
| Operating Income | 42.02B |
| Pretax Income | 41.78B |
| Net Income | 29.52B |
| EBITDA | 57.91B |
| EBIT | 42.02B |
| Earnings Per Share (EPS) | 252.38 |
Balance Sheet
The company has 62.35 billion in cash and 35.00 billion in debt, giving a net cash position of 27.35 billion or 233.87 per share.
| Cash & Cash Equivalents | 62.35B |
| Total Debt | 35.00B |
| Net Cash | 27.35B |
| Net Cash Per Share | 233.87 |
| Equity (Book Value) | 253.75B |
| Book Value Per Share | 2,169.67 |
| Working Capital | 83.12B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 25.29%, with operating and profit margins of 5.50% and 3.86%.
| Gross Margin | 25.29% |
| Operating Margin | 5.50% |
| Pretax Margin | 5.47% |
| Profit Margin | 3.86% |
| EBITDA Margin | 7.58% |
| EBIT Margin | 5.50% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 130.00, which amounts to a dividend yield of 3.21%.
| Dividend Per Share | 130.00 |
| Dividend Yield | 3.21% |
| Dividend Growth (YoY) | 14.02% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | 3.19% |
| Earnings Yield | 6.25% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 29, 2017. It was a forward split with a ratio of 2.
| Last Split Date | Mar 29, 2017 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Sundrug Co.,Ltd. has an Altman Z-Score of 5.11.
| Altman Z-Score | 5.11 |
| Piotroski F-Score | n/a |